In addition, it suggested that the PR-positive status and bilateral tumor location were associated with more discordance of HER2 status by pathological and clinical classification, respectively; while the invasive ductal cancer, compared with other histological type, was associated with less discordance of HER2 status by clinical classification. Here, ERBB2 is linked to neoplasm.